Surescripts: FTC must show predatory pricing, address Amex

The Federal Trade Commission must demonstrate that Surescripts implemented predatory pricing and caused anticompetitive harm to both sides of electronic prescription transactions, the health information company has said.

Get unlimited access to all Global Competition Review content